Crystal structures of a type-1 ribosome inactivating protein from Momordica balsamina in the bound and unbound states.
暂无分享,去创建一个
Punit Kaur | Sujata Sharma | T. Singh | P. Kaur | M. Sinha | Sujata Sharma | Tej P Singh | Mau Sinha | G. S. Kushwaha | N. Pandey | Gajraj Singh Kushwaha | Nisha Pandey | S Baskar Singh | S. B. Singh | T. Singh
[1] D I Stuart,et al. The N-glycosidase mechanism of ribosome-inactivating proteins implied by crystal structures of alpha-momorcharin. , 1994, Structure.
[2] E. V. Van Damme,et al. Ribosome‐inactivating proteins from plants: more than RNA N‐glycosidases? , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] Sheng-Xiang Lin,et al. Crystal structure of native cinnamomin isoform III and its comparison with other ribosome inactivating proteins , 2009, Proteins.
[4] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[5] K. Tsurugi,et al. RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. , 1987, The Journal of biological chemistry.
[6] H. Yeung,et al. Cloning of the cDNA of alpha-momorcharin: a ribosome inactivating protein. , 1991, Biochimica et biophysica acta.
[7] Peter Briggs,et al. A graphical user interface to the CCP4 program suite. , 2003, Acta crystallographica. Section D, Biological crystallography.
[8] N. Xuong,et al. The three-dimensional structure of ricin at 2.8 A. , 1987, The Journal of biological chemistry.
[9] V. Ghetie,et al. Immunotoxins in the therapy of cancer: from bench to clinic. , 1994, Pharmacology & therapeutics.
[10] J. Gariépy,et al. An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo , 2010, Molecular Cancer.
[11] Y. Pang,et al. Small-Molecule Inhibitor Leads of Ribosome-Inactivating Proteins Developed Using the Doorstop Approach , 2011, PloS one.
[12] R. Collins,et al. A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. , 1993, Blood.
[13] J. Pascal,et al. Structure and activity of an active site substitution of ricin A chain. , 1996, Biochemistry.
[14] V. Schramm,et al. Transition state analogues in structures of ricin and saporin ribosome-inactivating proteins , 2009, Proceedings of the National Academy of Sciences.
[15] A. Frankel,et al. Role of glutamic acid 177 of the ricin toxin A chain in enzymatic inactivation of ribosomes , 1989, Molecular and cellular biology.
[16] T. A. Walsh,et al. Characterization and molecular cloning of a proenzyme form of a ribosome-inactivating protein from maize. Novel mechanism of proenzyme activation by proteolytic removal of a 2.8-kilodalton internal peptide segment. , 1991, The Journal of biological chemistry.
[17] P. Shaw,et al. Cloning of the cDNA of α-momorcharin: a ribosome inactivating protein , 1991 .
[18] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[19] A. Monzingo,et al. X-ray analysis of substrate analogs in the ricin A-chain active site. , 1992, Journal of molecular biology.
[21] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[22] Q. Ma,et al. Crystal structure of β‐luffin, a ribosome‐inactivating protein, at 2.0 Å resolution , 2003 .
[23] Liqing Chen,et al. Atomic resolution structure of cucurmosin, a novel type 1 ribosome-inactivating protein from the sarcocarp of Cucurbita moschata. , 2008, Journal of structural biology.
[24] J. Robertus,et al. Crystallographic refinement of ricin to 2.5 Å , 1991, Proteins.
[25] L. Barbieri,et al. Isolation and Characterization of an RIP (Ribosome-Inactivating Protein)-Like Protein from Tobacco with Dual Enzymatic Activity1[w] , 2004, Plant Physiology.
[26] J. Richardson,et al. Role of arginine 180 and glutamic acid 177 of ricin toxin A chain in enzymatic inactivation of ribosomes , 1990, Molecular and cellular biology.
[27] L. Polito,et al. Immunotoxins and other conjugates: pre-clinical studies. , 2004, Mini reviews in medicinal chemistry.
[28] J. Robertus,et al. Site‐directed mutagenesis of ricin A‐chain and implications for the mechanism of action , 1991, Proteins.
[29] D. Derbyshire,et al. X-ray structure of recombinant ricin A-chain at 1.8 A resolution. , 1994, Journal of molecular biology.
[30] P. Wang,et al. A novel mechanism for inhibition of translation by pokeweed antiviral protein: depurination of the capped RNA template. , 2000, RNA.
[31] Liqing Chen,et al. X-ray sequence and crystal structure of luffaculin 1, a novel type 1 ribosome-inactivating protein , 2007, BMC Structural Biology.
[32] K. Tsurugi,et al. The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. , 1987, The Journal of biological chemistry.
[33] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[34] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[35] T. Boller,et al. Plant chitinases are potent inhibitors of fungal growth , 1986, Nature.
[36] G. Legname,et al. Single‐chain ribosome inactivating proteins from plants depurinate Escherichia coli 23S ribosomal RNA , 1991, FEBS letters.
[37] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[38] V. Schramm,et al. Transition-state analysis for depurination of DNA by Ricin A-chain , 2000 .
[39] S. Lee-Huang,et al. A new activity of anti-HIV and anti-tumor protein GAP31: DNA adenosine glycosidase--structural and modeling insight into its functions. , 2010, Biochemical and Biophysical Research Communications - BBRC.
[40] G. N. Ramachandran,et al. Conformation of polypeptides and proteins. , 1968, Advances in protein chemistry.
[41] S. Lee-Huang,et al. A new class of anti‐HIV agents: GAP31, DAPs 30 and 32 , 1991, FEBS letters.
[42] J. Navaza,et al. AMoRe: an automated package for molecular replacement , 1994 .
[43] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[44] L. Barbieri,et al. Ribosome-inactivating proteins from plants. , 1993, Biochimica et biophysica acta.
[45] S. Lee-Huang,et al. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[46] Z. Xia,et al. BETA-MOMORCHARIN STRUCTURE AT 2.55 A , 1999 .
[47] L. Barbieri,et al. Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: effect on DNA, RNA and poly(A). , 1997, Nucleic acids research.
[48] W. Delano. The PyMOL Molecular Graphics System (2002) , 2002 .
[49] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[50] J. Pascal,et al. 2.8‐Å crystal structure of a nontoxic type‐II ribosome‐inactivating protein, ebulin l , 2001, Proteins.
[51] F. Stirpe,et al. Description, distribution, activity and phylogenetic relationship of ribosome-inactivating proteins in plants, fungi and bacteria. , 2004, Mini reviews in medicinal chemistry.
[52] Jung-Yaw Lin,et al. A biophysical elucidation for less toxicity of Agglutinin than Abrin-a from the Seeds of Abrus Precatorius in consequence of crystal structure , 2010, Journal of Biomedical Science.
[53] Bijal A. Parikh,et al. Antiviral activity of ribosome inactivating proteins in medicine. , 2004, Mini reviews in medicinal chemistry.
[54] S. Wood,et al. Crystal structure of momordin, a type I Ribosome Inactivating Protein from the seeds of Momordica charantia , 1994, FEBS letters.